UIPATH INC - CLASS A (PATH)
US90364P1057 - Common Stock
We assign a fundamental rating of 5 out of 10 to PATH. PATH was compared to 280 industry peers in the Software industry. PATH has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PATH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PATH was profitable.
In the past year PATH had a positive cash flow from operations.
In the past 5 years PATH always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: PATH reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -3.44%, PATH perfoms like the industry average, outperforming 54.21% of the companies in the same industry.
PATH has a Return On Equity (-5.29%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.44% | ||
| ROE | -5.29% | ||
| ROIC | N/A |
ROA(3y)-11.83%
ROA(5y)-29.69%
ROE(3y)-16.3%
ROE(5y)-67.01%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of PATH (83.33%) is better than 89.38% of its industry peers.
PATH's Gross Margin has improved in the last couple of years.
PATH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 83.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y3.54%
2. Health
2.1 Basic Checks
PATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
PATH has more shares outstanding than it did 1 year ago.
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.59 indicates that PATH is not in any danger for bankruptcy at the moment.
PATH's Altman-Z score of 4.59 is fine compared to the rest of the industry. PATH outperforms 61.17% of its industry peers.
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.59 |
ROIC/WACCN/A
WACC11.56%
2.3 Liquidity
PATH has a Current Ratio of 3.13. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.13, PATH is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
A Quick Ratio of 3.13 indicates that PATH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.13, PATH is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.13 | ||
| Quick Ratio | 3.13 |
3. Growth
3.1 Past
PATH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.38%.
Looking at the last year, PATH shows a quite strong growth in Revenue. The Revenue has grown by 16.51% in the last year.
PATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 54.52% yearly.
EPS 1Y (TTM)6.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.33%
Revenue 1Y (TTM)16.51%
Revenue growth 3Y29.12%
Revenue growth 5Y54.52%
Sales Q2Q%8.81%
3.2 Future
The Earnings Per Share is expected to decrease by -0.74% on average over the next years.
The Revenue is expected to grow by 12.48% on average over the next years. This is quite good.
EPS Next Y-9.47%
EPS Next 2Y-1.44%
EPS Next 3Y2.59%
EPS Next 5Y-0.74%
Revenue Next Year11.28%
Revenue Next 2Y11.05%
Revenue Next 3Y10.87%
Revenue Next 5Y12.48%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.79, PATH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, PATH is valued a bit cheaper than 75.46% of the companies in the same industry.
PATH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.53, the valuation of PATH can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PATH indicates a somewhat cheap valuation: PATH is cheaper than 73.63% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, PATH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.79 | ||
| Fwd PE | 25.53 |
4.2 Price Multiples
PATH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PATH is cheaper than 81.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.84 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.44%
EPS Next 3Y2.59%
5. Dividend
5.1 Amount
PATH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
UIPATH INC - CLASS A
NYSE:PATH (1/8/2025, 3:42:06 PM)
13.395
+0.2 (+1.48%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners71.3%
Inst Owner Change0.01%
Ins Owners7.1%
Ins Owner Change0.27%
Market Cap7.36B
Analysts65.81
Price Target16.04 (19.75%)
Short Float %6.22%
Short Ratio3.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.57%
Min EPS beat(2)19.74%
Max EPS beat(2)47.41%
EPS beat(4)4
Avg EPS beat(4)28.41%
Min EPS beat(4)10.35%
Max EPS beat(4)47.41%
EPS beat(8)8
Avg EPS beat(8)105.15%
EPS beat(12)12
Avg EPS beat(12)110.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0%
Max Revenue beat(2)2.1%
Revenue beat(4)2
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-1.35%
Max Revenue beat(4)3.51%
Revenue beat(8)5
Avg Revenue beat(8)2.33%
Revenue beat(12)9
Avg Revenue beat(12)2.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.67%
PT rev (3m)1.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.95%
EPS NY rev (1m)20.55%
EPS NY rev (3m)26.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.79 | ||
| Fwd PE | 25.53 | ||
| P/S | 5.22 | ||
| P/FCF | 23.84 | ||
| P/OCF | 23 | ||
| P/B | 4.25 | ||
| P/tB | 4.51 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.5
EY3.73%
EPS(NY)0.52
Fwd EY3.92%
FCF(TTM)0.56
FCFY4.19%
OCF(TTM)0.58
OCFY4.35%
SpS2.57
BVpS3.15
TBVpS2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.44% | ||
| ROE | -5.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 83.33% | ||
| FCFM | 21.88% |
ROA(3y)-11.83%
ROA(5y)-29.69%
ROE(3y)-16.3%
ROE(5y)-67.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y3.54%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 56.41% | ||
| Cap/Sales | 0.8% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.13 | ||
| Quick Ratio | 3.13 | ||
| Altman-Z | 4.59 |
F-Score6
WACC11.56%
ROIC/WACCN/A
Cap/Depr(3y)82.84%
Cap/Depr(5y)103.27%
Cap/Sales(3y)1.43%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.33%
EPS Next Y-9.47%
EPS Next 2Y-1.44%
EPS Next 3Y2.59%
EPS Next 5Y-0.74%
Revenue 1Y (TTM)16.51%
Revenue growth 3Y29.12%
Revenue growth 5Y54.52%
Sales Q2Q%8.81%
Revenue Next Year11.28%
Revenue Next 2Y11.05%
Revenue Next 3Y10.87%
Revenue Next 5Y12.48%
EBIT growth 1Y21.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.83%
EBIT Next 3Y22.08%
EBIT Next 5Y21.54%
FCF growth 1Y329.06%
FCF growth 3Y123.91%
FCF growth 5YN/A
OCF growth 1Y390.99%
OCF growth 3Y117.22%
OCF growth 5YN/A